Showing results (1941-1950 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|December 13, 2025
Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapiesMartina Glavan, Jia Liu, Gisele Sampaio Silva, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
The Lancet. Neurology|December 20, 2024
Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trialNorbert Weidner, Rainer Abel, Doris Maier, et al.
The Lancet. Neurology|February 22, 2025
Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeuticsSarah Mizielinska, Guillaume M Hautbergue, Tania F Gendron, et al.
The Lancet. Neurology|February 22, 2025
Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe diseaseNadine A M E van der Beek, Maudy T M Theunissen, Johanna M P van den Hout, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.
The Lancet. Neurology|June 24, 2024
Bailout intracranial angioplasty or stenting following thrombectomy for acute large vessel occlusion in China (ANGEL-REBOOT): a multicentre, open-label, blinded-endpoint, randomised controlled trialFeng Gao, Xu Tong, Baixue Jia, et al.
The Lancet. Neurology|June 14, 2024
Safety and efficacy of stent retrievers plus contact aspiration in patients with acute ischaemic anterior circulation stroke and positive susceptibility vessel sign in France (VECTOR): a randomised, single-blind trialRomain Bourcier, Gaultier Marnat, Cyril Dargazanli, et al.
The Lancet. Neurology|November 17, 2023
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B Shieh, Nancy L Kuntz, James J Dowling, et al.
The Lancet. Neurology|October 20, 2023
Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer's diseaseKai Schlepckow, Estrella Morenas-Rodríguez, Soyon Hong, et al.
Pageof 200